Week in Review: Suzhou Innovent Announces $2 Billion Immunotherapy Collaboration With Roche
June 13, 2020 at 14:32 PM EDT
Suzhou Innovent Bio formed a far-reaching R&D collaboration with Roche that has a potential value of over $2 billion. Roche will have an option to license each product for ex-China development and commercialization.
